FTX Victims Seek Criminal Forfeiture of Company Assets
Different groups have filed competing claims for some or all of the assets involved in the criminal case against former FTX CEO Sam Bankman-Fried, who is currently serving a 25-year sentence in federal prison. In a filing in the US District Court for the Southern District of New York, lawyers representing FTX debtors and the company's Bahamian entity, FTX Digital Markets, argued that they have a "first right of refusal" on assets that could be used to satisfy the court's $11 billion judgment against Bankman-Fried. The legal team claimed that FTX's airplanes, funds held at Signature Bank, Farmington State Bank and Silvergate Bank, the sale of Robinhood stock and political contributions related to former FTX executives should not be applied to the Bankman-Fried judgment, but rather to the victims of the defunct exchange. The document states. Modifying the preliminary forfeiture order to provide for the return of specified property to the Debtor and/or FTX Digital will benefit all creditors and stakeholders in the Debtor's Chapter 11 bankruptcy proceeding and the liquidation of FTX Digital in the Bahamas, including the victims of Bankman-Fried's crimes," the document said. "
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
South Korea’s current account surplus in September exceeded 60 billions USD for the first time, with semiconductor exports becoming the main driver
Driven by booming semiconductor exports, South Korea's current account surplus in September surged to a record high.

CoreWeave (CRWV.US) bonds hit a new low as changes in Texas data center policies impact AI cloud trading
CoreWeave (CRWV.US) bonds fell sharply on Wednesday, with some dropping to new lows.

AstraZeneca (AZN.US) reportedly receives a $10 billion acquisition offer! Shares of obesity drug developer Rhythm (RYTM.US) soar in response
According to three people familiar with the matter, AstraZeneca previously proposed to acquire obesity drug developer Rhythm Pharmaceuticals for approximately 10 billion dollars.
Goldman Sachs and Apollo in Talks to Sell 40 Billion-Dollar AI Chip Financing for SpaceX (SPCX.US), Market's Willingness to Take Over Faces Test
Goldman Sachs (GS.US) and Apollo Global Management (APO.US) are in talks with Wall Street investors to begin selling portions of a roughly $40 billion chip financing deal for SpaceX (SPCX.US).
